Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes
Although several pharmacogenetic (PGx) predispositions affecting drug efficacy and safety are well established, drug selection and dosing as well as clinical trials are often performed in a non-pharmacogenetically-stratified manner, ultimately burdening healthcare systems. Pre-emptive PGx testing of...
Main Authors: | Sylvan M. Caspar, Timo Schneider, Janine Meienberg, Gabor Matyas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2308 |
Similar Items
-
Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
by: Heshu Abdullah-Koolmees, et al.
Published: (2021-01-01) -
Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
by: Maria-Theodora Pandi, et al.
Published: (2020-05-01) -
Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
by: Yuanhuang Chen, et al.
Published: (2021-06-01) -
What WGS Reveals about <i>Salmonella enterica</i> subsp. <i>enterica</i> in Wildlife in Germany
by: Laura Uelze, et al.
Published: (2021-09-01) -
Next-Generation Sequencing: The Translational Medicine Approach from “Bench to Bedside to Population”
by: Mohammad Muzafar Beigh
Published: (2016-06-01)